This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ballard, J. D.
Right arrow Articles by Starnbach, M. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ballard, J. D.
Right arrow Articles by Starnbach, M. N.

 Previous Article  |  Next Article 

Infect Immun, February 1998, p. 615-619, Vol. 66, No. 2
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Anthrax Toxin-Mediated Delivery In Vivo and In Vitro of a Cytotoxic T-Lymphocyte Epitope from Ovalbumin

Jimmy D. Ballard, Amy M. Doling, Kathryn Beauregard, R. John Collier, and Michael N. Starnbach*

Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115

Received 14 August 1997/Returned for modification 15 October 1997/Accepted 20 November 1997

We reported earlier that a nontoxic form of anthrax toxin was capable of delivering a cytotoxic T-lymphocyte (CTL) epitope in vivo, such that a specific CTL response was primed against the epitope. The epitope, of bacterial origin, was fused to an N-terminal fragment (LFn) from the lethal-factor component of the toxin, and the fusion protein was injected, together with the protective antigen (PA) component, into BALB/c mice. Here we report that PA plus LFn is capable of delivering a different epitope---OVA257-264 from ovalbumin. Delivery was accomplished in a different mouse haplotype, H-2Kb and occurred in vitro as well as in vivo. An OVA257-264-specific CTL clone, GA-4, recognized EL-4 cells treated in vitro with PA plus as little as 30 fmol of the LFn-OVA257-264 fusion protein. PA mutants attenuated in toxin self-assembly or translocation were inactive, implying that the role of PA in epitope delivery is the same as that in toxin action. Also, we showed that OVA257-264-specific CTL could be induced to proliferate by incubation with splenocytes treated with PA plus LFn-OVA257-264. These findings imply that PA-LFn may serve as a general delivery vehicle for CTL epitopes in vivo and as a safe, efficient tool for the ex vivo expansion of patient-derived CTL for use in adoptive immunotherapy.


* Corresponding author. Mailing address: Department of Microbiology and Molecular Genetics, Harvard Medical School, 200 Longwood Ave., Boston, MA 02115. Phone: (617) 632-1873. Fax: (617) 738-7664. E-mail: mstarnba{at}warren.med.harvard.edu.




This article has been cited by other articles:

  • Taft, S. C., Weiss, A. A. (2008). Toxicity of Anthrax Toxin Is Influenced by Receptor Expression. CVI 15: 1330-1336 [Abstract] [Full Text]  
  • Shaw, C. A., Starnbach, M. N. (2008). Both CD4+ and CD8+ T Cells Respond to Antigens Fused to Anthrax Lethal Toxin. Infect. Immun. 76: 2603-2611 [Abstract] [Full Text]  
  • Shaw, C. A., Starnbach, M. N. (2008). Antigen Delivered by Anthrax Lethal Toxin Induces the Development of Memory CD8+ T Cells That Can Be Rapidly Boosted and Display Effector Functions. Infect. Immun. 76: 1214-1222 [Abstract] [Full Text]  
  • Shaw, C. A., Starnbach, M. N. (2006). Stimulation of CD8+ T Cells following Diphtheria Toxin-Mediated Antigen Delivery into Dendritic Cells. Infect. Immun. 74: 1001-1008 [Abstract] [Full Text]  
  • Steele, L. N., Balsara, Z. R., Starnbach, M. N. (2004). Hematopoietic Cells Are Required to Initiate a Chlamydia trachomatis-Specific CD8+ T Cell Response. J. Immunol. 173: 6327-6337 [Abstract] [Full Text]  
  • Barth, H., Aktories, K., Popoff, M. R., Stiles, B. G. (2004). Binary Bacterial Toxins: Biochemistry, Biology, and Applications of Common Clostridium and Bacillus Proteins. Microbiol. Mol. Biol. Rev. 68: 373-402 [Abstract] [Full Text]  
  • Kushner, N., Zhang, D., Touzjian, N., Essex, M., Lieberman, J., Lu, Y. (2003). A fragment of anthrax lethal factor delivers proteins to the cytosol without requiring protective antigen. Proc. Natl. Acad. Sci. USA 100: 6652-6657 [Abstract] [Full Text]  
  • Ichinose, M., Liu, X.-H., Hagihara, N., Youle, R. J. (2002). Extracellular Bad Fused to Toxin Transport Domains Induces Apoptosis. Cancer Res. 62: 1433-1438 [Abstract] [Full Text]  
  • Liu, X.-H., Collier, R. J., Youle, R. J. (2001). Inhibition of Axotomy-induced Neuronal Apoptosis by Extracellular Delivery of a Bcl-XL Fusion Protein. J. Biol. Chem. 276: 46326-46332 [Abstract] [Full Text]  
  • Marvaud, J.-C., Smith, T., Hale, M. L., Popoff, M. R., Smith, L. A., Stiles, B. G. (2001). Clostridium perfringens Iota-Toxin: Mapping of Receptor Binding and Ia Docking Domains on Ib. Infect. Immun. 69: 2435-2441 [Abstract] [Full Text]  
  • Haicheur, N., Bismuth, E., Bosset, S., Adotevi, O., Warnier, G., Lacabanne, V., Regnault, A., Desaymard, C., Amigorena, S., Ricciardi-Castagnoli, P., Goud, B., Fridman, W. H., Johannes, L., Tartour, E. (2000). The B Subunit of Shiga Toxin Fused to a Tumor Antigen Elicits CTL and Targets Dendritic Cells to Allow MHC Class I-Restricted Presentation of Peptides Derived from Exogenous Antigens. J. Immunol. 165: 3301-3308 [Abstract] [Full Text]  
  • Lu, Y., Friedman, R., Kushner, N., Doling, A., Thomas, L., Touzjian, N., Starnbach, M., Lieberman, J. (2000). Genetically modified anthrax lethal toxin safely delivers whole HIV protein antigens into the cytosol to induce T cell immunity. Proc. Natl. Acad. Sci. USA 97: 8027-8032 [Abstract] [Full Text]  
  • Liu, X.-H., Castelli, J. C., Youle, R. J. (1999). Receptor-mediated uptake of an extracellular Bcl-xL fusion protein inhibits apoptosis. Proc. Natl. Acad. Sci. USA 96: 9563-9567 [Abstract] [Full Text]  
  • Doling, A. M., Ballard, J. D., Shen, H., Krishna, K. M., Ahmed, R., Collier, R. J., Starnbach, M. N. (1999). Cytotoxic T-Lymphocyte Epitopes Fused to Anthrax Toxin Induce Protective Antiviral Immunity. Infect. Immun. 67: 3290-3296 [Abstract] [Full Text]  
  • Beauregard, K. E., Wimer-Mackin, S., Collier, R. J., Lencer, W. I. (1999). Anthrax Toxin Entry into Polarized Epithelial Cells. Infect. Immun. 67: 3026-3030 [Abstract] [Full Text]  
  • Fayolle, C., Ladant, D., Karimova, G., Ullmann, A., Leclerc, C. (1999). Therapy of Murine Tumors with Recombinant Bordetella pertussis Adenylate Cyclase Carrying a Cytotoxic T Cell Epitope. J. Immunol. 162: 4157-4162 [Abstract] [Full Text]  
  • Guermonprez, P., Ladant, D., Karimova, G., Ullmann, A., Leclerc, C. (1999). Direct Delivery of the Bordetella pertussis Adenylate Cyclase Toxin to the MHC Class I Antigen Presentation Pathway. J. Immunol. 162: 1910-1916 [Abstract] [Full Text]  
  • Ballard, J. D., Collier, R. J., Starnbach, M. N. (1998). Anthrax Toxin as a Molecular Tool for Stimulation of Cytotoxic T Lymphocytes: Disulfide-Linked Epitopes, Multiple Injections, and Role of CD4+ Cells. Infect. Immun. 66: 4696-4699 [Abstract] [Full Text]